Phase II study of sunitinib in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.
Saved in:
| Title: | Phase II study of sunitinib in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis. |
|---|---|
| Authors: | Apostolidou E; Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA., Kantarjian H, Thomas D, Burger I, Borthakur G, Verstovsek S |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2010 Aug; Vol. 10 (4), pp. 281-4. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 20709665 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase II study of sunitinib in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Apostolidou+E%22">Apostolidou E</searchLink>; Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Kantarjian+H%22">Kantarjian H</searchLink><br /><searchLink fieldCode="AU" term="%22Thomas+D%22">Thomas D</searchLink><br /><searchLink fieldCode="AU" term="%22Burger+I%22">Burger I</searchLink><br /><searchLink fieldCode="AU" term="%22Borthakur+G%22">Borthakur G</searchLink><br /><searchLink fieldCode="AU" term="%22Verstovsek+S%22">Verstovsek S</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2010 Aug; Vol. 10 (4), pp. 281-4. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20709665 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3816/CLML.2010.n.058 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 281 Titles: – TitleFull: Phase II study of sunitinib in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Apostolidou E – PersonEntity: Name: NameFull: Kantarjian H – PersonEntity: Name: NameFull: Thomas D – PersonEntity: Name: NameFull: Burger I – PersonEntity: Name: NameFull: Borthakur G – PersonEntity: Name: NameFull: Verstovsek S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2010 Aug Type: published Y: 2010 Identifiers: – Type: issn-electronic Value: 2152-2669 Numbering: – Type: volume Value: 10 – Type: issue Value: 4 Titles: – TitleFull: Clinical lymphoma, myeloma & leukemia Type: main |
| ResultId | 1 |
